Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
31.84
+1.01 (3.28%)
May 29, 2025, 4:00 PM - Market closed
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $1.84 billion as of May 29, 2025. Its market cap has decreased by -1.57% in one year.
Market Cap
1.84B
Enterprise Value
472.33M
1-Year Change
-1.57%
Ranking
Category
Stock Price
$31.84
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $1.84B, an increase of 100.66%. That is a compound annual growth rate of 6.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 28, 2025 | 1.79B | -4.72% |
Dec 31, 2024 | 1.87B | 50.56% |
Dec 29, 2023 | 1.24B | -19.33% |
Dec 30, 2022 | 1.54B | -13.57% |
Dec 31, 2021 | 1.79B | -40.52% |
Dec 31, 2020 | 3.00B | 6.73% |
Dec 31, 2019 | 2.81B | 4.81% |
Dec 31, 2018 | 2.68B | -3.76% |
Dec 29, 2017 | 2.79B | 58.97% |
Dec 30, 2016 | 1.75B | -28.25% |
Dec 31, 2015 | 2.44B | -37.12% |
Dec 31, 2014 | 3.89B | 420.55% |
Dec 31, 2013 | 746.50M | -18.77% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 648.68B |
Johnson & Johnson | 369.52B |
AbbVie | 327.88B |
Novo Nordisk | 305.07B |
UnitedHealth Group | 270.48B |
Abbott Laboratories | 231.14B |
Novartis AG | 219.70B |
AstraZeneca | 217.50B |